Sharp cuts in price of cancer drugs expose excessive pricing, say health experts
NPPA releases revised MRPs for 543 brands of anti-cancer medicines with the new prices effective from November 9; Jan Swasthya Abhiyan India (JSA India) says controlling trade margins alone is insufficient as life-saving cancer treatment must be affordable based on medical need, not a patient’s ability to pay
· 10/28/2026, 4:05:42 PM· 2 min read
NPPA releases revised MRPs for 543 brands of anti-cancer medicines with the new prices effective from November 9; Jan Swasthya Abhiyan India (JSA India) says controlling trade margins alone is insufficient as life-saving cancer treatment must be affordable based on medical need, not a patient’s ability to pay
Read original story →Related stories
india
How AI-assisted research ‘fuelled’ a spurious liquor racket in Madhya Pradesh’s Dewas
india
‘Selective action’: Kuki-Zo Council warns of pulling MLAs out Manipur govt, ask armed groups to reconsider truce pact
india
Cyclone Arnab: Heavy inflows swell rivers across three North Andhra districts
india